Horizon Pharma plc Withdraws Offer to Acquire Depomed, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Funds sell $44bn in semiconductors on AI concerns
Jefferies Reinstates Horizon Pharma (HZNP) at Buy
November 23, 2015 7:39 AM ESTJefferies reinstates coverage on Horizon Pharma (NASDAQ: HZNP) with a Buy rating and a price target of $32.00 (from $37.00), saying standalone growth appears healthy and near-term M&A is likely.
Analyst David Steinberg commented, "HZNP abandoned its hostile takeover attempt of DEPO following... More
Depomed (DEPO) Issues Commentary on Horizon Pharma's (HZNP) Revoked Acquisition Proposal
November 20, 2015 6:57 AM ESTDepomed (Nasdaq: DEPO) issued the following statement regarding Horizon Pharma plc's (Nadaq: HZNP) decision to withdraw its... More
Horizon Pharma (HZNP) Withdraws Offer to Acquire Depomed (DEPO)
November 19, 2015 8:18 PM ESTHorizon Pharma (Nasdaq: HZNP) announced that at a hearing held today, Judge Peter Kirwan of the Superior Court of California for the County of Santa Clara granted Depomed Inc.'s (Nasdaq: DEPO) motion for preliminary injunctive relief against Horizon Pharma's alleged use of... More
